Tullis Growth Fund II, 10% Owner of Exagen XGN, has filed 1 purchase and 0 sales on the open market. The latest trade was on 23/06/15.

TI

TI

Tullis Growth Fund II

10% Owner

Company

Exagen XGN

First filing

23/06/20

Trades

1 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

23/06/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
ExagenXGN	Open-market buy	23/06/15	23/06/20	167 sh	$3.11	$519.37	+0.0%